Merck KGaA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0006599905
  • ETR: MRK
EUR
136.90
2.45 (1.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
5,434.00
5,134.00
5,249.00
5,318.00
5,255.00
5,280.00
5,418.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,434.00
5,134.00
5,249.00
5,318.00
5,255.00
5,280.00
5,418.00
Raw Material Cost
2,268.00
2,069.00
2,288.00
2,105.00
2,228.00
2,135.00
2,319.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
137.00
104.00
121.00
126.00
79.00
78.00
76.00
Selling and Distribution Expenses
1,313.00
1,415.00
1,516.00
1,335.00
1,411.00
1,417.00
1,554.00
Other Expenses
54.70
55.40
54.30
53.40
46.00
47.30
45.10
Total Expenditure (Excl Depreciation)
4,265.00
4,142.00
4,468.00
4,100.00
4,178.00
4,103.00
4,400.00
Operating Profit (PBDIT) excl Other Income
1169
992
781
1218
1077
1177
1018
Other Income
-79.00
88.00
-188.00
146.00
-76.00
-91.00
-84.00
Operating Profit (PBDIT)
1,653.00
1,577.00
1,503.00
1,822.00
1,458.00
1,559.00
1,485.00
Interest
137.00
104.00
121.00
126.00
79.00
78.00
76.00
Exceptional Items
-312.00
-108.00
-71.00
-116.00
-93.00
-51.00
-48.00
Gross Profit (PBDT)
3,166.00
3,065.00
2,961.00
3,213.00
3,027.00
3,145.00
3,099.00
Depreciation
563.00
497.00
910.00
458.00
457.00
473.00
551.00
Profit Before Tax
640.00
869.00
401.00
1,122.00
829.00
956.00
809.00
Tax
146.00
200.00
77.00
224.00
174.00
218.00
140.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
490.00
660.00
319.00
902.00
652.00
735.00
666.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
490.00
660.00
319.00
902.00
652.00
735.00
666.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.00
9.00
5.00
-4.00
3.00
3.00
3.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
494.00
669.00
324.00
898.00
655.00
738.00
669.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
30,172.00
29,742.00
28,592.00
28,936.00
28,258.00
29,823.00
29,912.00
Earnings per share (EPS)
1.13
1.52
0.73
2.07
1.5
1.69
1.53
Diluted Earnings per share
1.13
1.52
0.73
2.07
1.5
1.69
1.53
Operating Profit Margin (Excl OI)
21.51%
19.32%
14.88%
22.9%
20.49%
22.29%
18.79%
Gross Profit Margin
22.14%
26.61%
24.98%
29.71%
24.47%
27.06%
25.1%
PAT Margin
9.02%
12.86%
6.08%
16.96%
12.41%
13.92%
12.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 5.84% vs -2.19% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -26.16% vs 106.48% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 16.32% vs -11.95% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 31.73% vs -14.05% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Merck KGaA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
5,434.00
10,872.00
-5,438.00
-50.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,434.00
10,872.00
-5,438.00
-50.02%
Raw Material Cost
2,268.00
4,540.00
-2,272.00
-50.04%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
2,985.00
-2,985.00
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
137.00
612.00
-475.00
-77.61%
Selling and Distribution Expenses
1,313.00
3,925.00
-2,612.00
-66.55%
Other Expenses
54.70
-207.90
262.60
126.31%
Total Expenditure (Excl Depreciation)
4,265.00
9,983.00
-5,718.00
-57.28%
Operating Profit (PBDIT) excl Other Income
1,169.00
889.00
280.00
31.50%
Other Income
-79.00
232.00
-311.00
-134.05%
Operating Profit (PBDIT)
1,653.00
2,279.00
-626.00
-27.47%
Interest
137.00
612.00
-475.00
-77.61%
Exceptional Items
-312.00
-174.00
-138.00
-79.31%
Gross Profit (PBDT)
3,166.00
6,332.00
-3,166.00
-50.00%
Depreciation
563.00
1,158.00
-595.00
-51.38%
Profit Before Tax
640.00
335.00
305.00
91.04%
Tax
146.00
92.00
54.00
58.70%
Provisions and contingencies
0
0
0.00
Profit After Tax
490.00
219.00
271.00
123.74%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
490.00
219.00
271.00
123.74%
Share in Profit of Associates
0
0
0.00
Minority Interest
4.00
10.00
-6.00
-60.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
494.00
229.00
265.00
115.72%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
30,172.00
29,584.00
588.00
1.99%
Earnings per share (EPS)
1.13
0.22
0.91
413.64%
Diluted Earnings per share
1.13
0.22
0.91
413.64%
Operating Profit Margin (Excl OI)
21.51%
8.18%
0.00
13.33%
Gross Profit Margin
22.14%
13.73%
0.00
8.41%
PAT Margin
9.02%
2.01%
0.00
7.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 543.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 5.84% vs -2.19% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 3.41% vs -1.81% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 49.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -26.16% vs 106.48% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -24.58% vs 8.26% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 173.20 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 16.32% vs -11.95% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 12.91% vs -16.59% in Jun 2025

Quarterly - Interest
Interest 13.70 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 31.73% vs -14.05% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 73.42% vs 9.72% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.51%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading